Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Debridement & negative-pressure wound therapy · Delaware | Debridement & negative-pressure wound therapy · Florida | |
|---|---|---|
| Surgeons, 2024 | 57 | 1,336 |
| Medicare fee-for-service cases | 12,034 | 505,568 |
| Growth since 2019 (Medicare FFS) | +3.1%/yr | +2.5%/yr |
| Forecast cases (Medicare FFS) | 18,400 in 2030 | 587,700 in 2030 |
| Forecast growth | +7.3%/yr to 2030 | +2.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 68.1 | 215.0 |
| Medicare Advantage share | 35% | 60% |
| Out of hospital | 37% (−8 pts since 2019) | 54% (+1 pts since 2019) |
| Cases per surgeon | 211 | 378 |
| Top 10 surgeons' share | 59% | 13% |
| Surgeons growing | 12 | 263 |
| New since the base year | 18 | 460 |
| Likely to stop billing it | 11 by 2026 | 210 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $3,832 | $1,233 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.